37415-62-6 Usage
Uses
Used in Pharmaceutical Industry:
4-Hexenoic acid,6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-,sodium salt (1:1), (4E)is used as a pharmaceutical agent for its potential therapeutic effects. The complex structure of the molecule may allow it to interact with specific biological targets, such as enzymes or receptors, to modulate their activity and produce a desired therapeutic effect.
Used in Cosmetic Industry:
In the cosmetic industry, 4-Hexenoic acid,6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-,sodium salt (1:1), (4E)may be used as an active ingredient in skincare products. Its unique chemical structure could provide benefits such as anti-aging, skin brightening, or moisturizing properties, making it a valuable component in cosmetic formulations.
Used in Agrochemical Industry:
4-Hexenoic acid,6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-,sodium salt (1:1), (4E)may also find applications in the agrochemical industry. Its complex structure could potentially be utilized in the development of novel pesticides or herbicides, offering new options for crop protection and management.
Used in Environmental Contaminant Management:
Given its ionic properties, 4-Hexenoic acid,6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-,sodium salt (1:1), (4E)could be employed in the management of environmental contaminants. It may be used to sequester or neutralize harmful substances, such as heavy metals or pollutants, thereby reducing their impact on the environment and human health.
Used in Food Contaminant Management:
Similarly, in the food industry, this compound may be used to address food contaminant issues. Its ability to form complexes with other ions could be leveraged to remove or reduce the presence of contaminants in food products, ensuring safety and quality for consumers.
Originator
Novartis (Switzerland)
Synthesis
Mycophenolic
acid (137) was originally synthesized by Birch and Wright
and has been the subject of several total and
formal syntheses. The large production in industry is
done via fermentation. A concise synthesis of
mycophenolic acid published recently is depicted in Scheme
17. Reaction of dimethyl 1,3-acetonedicarboxylate (128)
with commercially available geranyl chloride (129) in the
presence of NaH gave ketoester 130 in 82% yield. Treatment
of ketoester 130 with 4-(pivolyloxy)-2-butynal (131) in the
presence of NaH provided resorcinol 132 in a single step
with all substituents in place in 33% yield along with two
more compounds represented by 133 (62%). Resorcinol 132
was transformed into 134 via a four step sequences:
methylation with NaH and MeI in dry DMF, reduction of
the formyl group with NaBH4, mesylation of the resulting
alcohol and subsequent reduction of the mesylate. The
preparation of phthalide 135 was affected in quantitative
yield on treatment of 134 with K2CO3 in dry MeOH.
Selective ozonolysis of compound 135, followed by Jones
oxidation and esterification afforded ester 136.
Demethylation with BCl3 in DCM followed by hydrolysis
of the ester function gave the mycophenolic acid (137). The
mycophenolic acid was then converted to its sodium salt
XVII (no conditions and yield available）.
Check Digit Verification of cas no
The CAS Registry Mumber 37415-62-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,4,1 and 5 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 37415-62:
(7*3)+(6*7)+(5*4)+(4*1)+(3*5)+(2*6)+(1*2)=116
116 % 10 = 6
So 37415-62-6 is a valid CAS Registry Number.
InChI:InChI=1/C17H20O6.Na/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3;/h4,20H,5-8H2,1-3H3,(H,18,19);/q;+1/p-1
